DexCom, Inc. (NASDAQ:DXCM) Q1 2025 Earnings Call Transcript
Operator: Welcome to the DexCom First Quarter 2025 Earnings Release Conference Call. My name is Louella, and I will be your operator for today's call.
Dexcom Inc (DXCM)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bailard Inc Thomas Bailard | 57,707 | $3,940,811 | -2% | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $50.01 | 25,000 | Director | 58,502 | 2017-11-07 | Filing | |
| $49.61 | 10,000 | Director | 33,502 | 2017-11-06 | Filing | |
| $15.50 | 70,000 | Director | 121,975 | 2013-03-11 | Filing | |
| $10.37 | 1,000 | Director | 6,000 | 2012-03-08 | Filing | |
| $10.34 | 1,000 | Director | 5,000 | 2012-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.33 | 352 | Director | 22,997 | 2025-03-17 | Filing | |
| $70.38 | 14,076 | Officer | 313,497 | 2025-03-12 | Filing | |
| $70.38 | 13,000 | Officer | 105,602 | 2025-03-12 | Filing | |
| $70.38 | 12,001 | Officer | 123,481 | 2025-03-12 | Filing | |
| $70.38 | 11,176 | Officer | 115,805 | 2025-03-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 39,241,177 | $2,679,779,952 | 0.06% | |
| 2. | 4,476,653 | $305,710,553 | 0.06% | |
| 3. | 3,194,829 | $218,174,872 | 0.07% | |
| 4. | 1,647,333 | $112,496,371 | 2.73% | |
| 5. | 1,159,747 | $79,199,123 | 0.59% |
News See All
DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns
Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A copy of the same can be downloaded here.
10 Best Diabetes Stocks To Buy According to Billionaires
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.
10 Best Growth Stocks Under $100 to Buy Now
Growth stocks are shares of companies which are expected to grow their revenue and earnings at a faster rate than the market average.
12 Best Internet of Things Stocks To Buy According to Analysts
According to the IOT analytics, 2024 was a poor year for the Internet of Things sector, particularly due to the headwinds from the hardware sector.
DexCom, Inc. (NASDAQ:DXCM) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the DexCom, Inc.
10 Best Medical Device Stocks To Buy According to Hedge Funds
According to a report by Mordor Intelligence, the medical devices market has a size of $681.57 billion as of 2025.
Here’s Why Aristotle Atlantic Focus Growth Strategy Sold its Stake in DexCom (DXCM)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The U.S.
Jim Cramer Discussed These 10 NASDAQ 100 Stocks Recently
Jim Cramer, the host of Mad Money, recently shared his perspective on the stock market, especially reflecting on the events of 2024.
AI-Driven Glucose Biosensing: Dexcom's (DXCM) Path To A Comeback
Dexcom has become the first company to launch a generative AI-powered continuous glucose monitor.
Billionaire Hedge Funds
